Progressive breathlessness in an Afro Caribbean hypertensive subject by Dwivedi, Girish et al.
CASE REPORT
Cardiology Journal
2012, Vol. 19, No. 6, pp. 646–649
10.5603/CJ.2012.0120
Copyright © 2012 Via Medica
ISSN 1897–5593
646 www.cardiologyjournal.org
Address for correspondence: Dr. Girish Dwivedi, MD, DM, MRCP (UK), PhD, Clinical Lecturer in Cardiology,
Department of Cardiovascular Medicine, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT,
United Kingdom, tel: +44 121 5075080, e-mail: g.dwivedi@bham.ac.uk
Received: 16.11.2011 Accepted: 19.11.2011
Progressive breathlessness in an
Afro Caribbean hypertensive subject
Girish Dwivedi1, Robert J. MacFadyen2, Chetan Varma2,
Vishal Sharma1, Desley Neil1, Richard P. Steeds1
1University Hospital Birmingham NHS Foundation Trust and University of Birmingham,
Birmingham, United Kingdom
2Sandwell and West Birmingham NHS Trust, City Hospital, Dudley Road, Birmingham, United Kingdom
Abstract
The sensitivity and specificity of structural assessment of the heart by echocardiography in
black hypertensive patients presenting with symptoms of heart failure is often incomplete.
Cardiovascular magnetic resonance, mainly by virtue of its ability to characterize myocardial
tissue composition, may be of value in differentiating some of the common pathologies
noninvasively. We present an illustrative case of hypertrophic cardiomyopathy in a British
Afro Caribbean hypertensive patient where at least some features of familial amyloidosis were
present on screening echocardiography. Cardiovascular magnetic resonance examination of
this case established not only the usefulness of this technique, but also highlighted the importance
of recognizing the variations and departure from the usual which one associates with hyper-
trophic cardiomyopathy, so as to arrive at the final diagnosis. (Cardiol J 2012; 19, 6: 646–649)
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Introduction
The sensitivity and specificity of structural as-
sessment of the heart by echocardiography in black
patients with hypertension is poor [1]. In such sub-
jects, there is a need to differentiate a range of
structural changes that manifest as increased wall
thickness: hypertensive heart disease; hypertrophic
disease (inherited cardiomyopathies) as well as in-
filtrative heart disease such as familial transthyre-
tin-related (TTR) amyloidosis and Anderson Fabry
disease [2–4]. This can be challenging using
echocardiography alone, as the sensitivity and spe-
cificity of changes are generally inadequate for any
purpose other than as a screening tool.
Cardiovascular magnetic resonance (CMR), by
virtue of its ability to assess structure and func-
tion, define valvular and/or pericardial changes,
and give information on myocardial tissue charac-
terization, has the potential to differentiate such
pathology in these subjects [5–7]. Differing hyper-
enhancement patterns are observed in a variety of
non-ischemic cardiomyopathies on delayed inver-
sion recovery sequences following gadolinium in-
jection [5–7].
We illustrate the potential of CMR techniques
in Afro Caribbean subjects using an indicative case
where hyper-enhancement patterns on CMR
proved valuable in differentiating hypertrophic car-
diomyopathy (HCM).
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Case report
A 57 year-old Afro Caribbean, hypertensive
male was referred from his family doctor with un-
diagnosed progressive breathlessness on exertion
over six months. He had a history of arterial hyper-
tension for 18 years (secondary causes excluded)
and had undergone partial left (18 months prior) and
right (12 months prior) nephrectomy for bilateral
renal cell carcinoma. There was no personal or fami-
ly history of any form of heart disease or sudden
cardiac death. He was not affected by orthopnea or
paroxysmal nocturnal dyspnea, and complained only
of non-specific exercise limitation. There were no
relevant respiratory symptoms, occupational histo-
ry or exposures.
General physical examination revealed a heavi-
ly built man with a pulse rate of 80 bpm and treated
(candesartan, doxazozin, minoxidil and metalozone)
clinic blood pressure of ~134/68 mm Hg on repeat-
ed readings in the left arm. Jugular venous pressure
was normal with no pedal edema. Chest and cardio-
vascular system were otherwise unremarkable.
A 12-lead electrocardiogram demonstrated
voltage left ventricular (LV) hypertrophy with
a typical lateral strain pattern. Echocardiography
confirmed severe concentric LV hypertrophy (max
LV wall thickness: 2 cm) with mild biatrial dilatation
and a global pericardial effusion (maximum depth:
1.4 cm). The LV ejection fraction was normal. The
LV and right ventricular (RV) long axis functions
(mitral and tricuspid annular excursions) were
clearly preserved. The ratio of early mitral inflow
velocity (E) to lateral mitral annulus early velocity
(e’) indicated elevated LV end-diastolic pressure
(E/e’ = 18). Notably, the echocardiography showed
thickening of the RV (free wall: 1 cm), atrial sep-
tum, and valvular structures along with the non-
specific granular pattern of myocardial reflectivity
characterized as septal ‘speckling’ of myocardial tex-
ture (Fig. 1). No systolic anterior motion of the mi-
tral valve or LV outflow tract gradient suggestive of
obstructive cardiomyopathy was observed at rest.
The probable diagnosis of HCM or hyperten-
sive heart disease was considered. However, given
the Afro Caribbean phenotype, CMR was organized
to exclude TTR amyloidosis. This has been de-
scribed in the African American population, and was
a possibility due to the unexpected findings of
a pericardial effusion, atrial septal, RV and valvular
thickening along with the granular speckling pat-
tern of myocardium seen on the echocardiogram
[3, 4]. In addition, a ventricular biopsy from the right
internal jugular vein under lidocaine local anesthetic
was completed to provide three samples of septal
myocardium for histological analysis.
The CMR examination revealed a global peri-
cardial effusion [maximum depth 1 cm adjacent to
the anterolateral wall], concentric severe LV hyper-
trophy [maximum dimension of 2.3 cm; LV mass of
364 gm absolute] (Fig. 2A) with a small LV end sys-
tolic cavity and flow acceleration within the LV ca-
vity (Fig. 2B). The RV wall thickness was increased
(0.7 cm) with normal systolic function. On longitu-
dinal relaxation time (T1) mapping there was
a strong suspicion of early subendocardial passage
through the null point. The late gadolinium en-
hancement images showed generally poor nulling
with diffuse linear mid-myocardial wall hyper-en-
hancement that was most apparent in the mid and
basal inferolateral and anterolateral LV segments
(Fig. 3). In addition, the basal insertion points of the
RV into the septum also demonstrated mid myocar-
dial wall hyper-enhancement. These appearances
were compatible with either HCM or Anderson
Fabry disease. However, primary cardiac amyloi-
dosis could not be excluded on the basis of the T1
mapping findings. Anderson Fabry disease was ex-
cluded by demonstrating normal level of alpha-ga-
lactosidase activity. Cardiac amyloidosis was ex-
cluded by the cardiac biopsy which was consistent
with a tissue diagnosis of HCM.
Figure 1. Modified apical five-chamber view demon-
strating significant pericardial effusion, thickened car-
diac structures (IAS — inter atrial septum; IVS — inter
ventricular septum; AML — anterior mitral leaflet; right
ventricle [RV] free wall) and characteristic granular spec-
kling myocardial architecture.
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Discussion
Hypertensive Afro Caribbean patients present
specific diagnostic challenges due to their in-
creased susceptibility to cardiac complications
secondary to hypertension and their different re-
lative responsiveness to a range of anti-hyperten-
sive drug treatments [1]. Differentiating these
subjects from more generalized forms of inherit-
ed HCM, or indeed dilated cardiomyopathy (which
may simply be an end stage response to poor long
term blood pressure control), is often attempted
using echocardiography. This is compromised by
poor image quality, the non-specific and insensi-
tive nature of the findings and a failure to consi-
der alternative tissue diagnoses.
HCM is a broad range of inherited primary
myocardial diseases characterized by abnormal
myocyte proliferation and interstitial thickening of
the myocardium. CMR using late gadolinium pro-
filing in HCM patients typically demonstrates
patchy, multi focal hyper-enhancement occurring
within the hypertrophied regions. The junction of
the RV free wall with the interventricular septum
(i.e. RV insertion points) is frequently affected
[8, 9]. Recent reports suggest that the extent of de-
layed hyper-enhancement in HCM may have ad-
verse prognostic implications [7–9]. It is believed
that the patchy enhancement in HCM is due to the
presence of abundant connective tissue within the
hypertrophic myocardium, although it could also be
due to necrosis caused by relative ischemia [8, 9].
Figure 2. A. Apical four-chamber view on cardiovascular magnetic resonance (CMR) showing thickened septal and
lateral walls (black arrows) and thickened right ventricle free wall (white arrow); B. Flow acceleration seen within the
left ventricle (white arrow) and pericardial effusion (black arrow) on CMR. Note small end systolic cavity size.
A B
Figure 3. A. Basal short axis late gadolinium enhancement image demonstrating diffuse linear mid myocardial wall
hyper-enhancement in anterolateral and inferolateral walls (white arrows). Note: Hyper-enhancement also seen at
right ventricle insertion points into the septum (black arrows); B. Apical four-chamber view showing mid myocardial
wall hyper-enhancement in the basal inferolateral left ventricle segment (white arrows).
A B
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Familial cardiac amyloidosis in Afro Caribbean
patients, usually due to TTR valine substitution, is
a complex inherited phenotype but frequently coexi-
sts with hypertension in old age in this community
[3, 4]. This generally involves diffuse infiltration of
myocardium and valvular tissue with fibrillar amy-
loid protein, typically displaying subendocardial lin-
ear global and diffuse hyper-enhancement [10, 11].
Early gadolinium kinetics may also have a role in
the diagnosis of cardiac amyloidosis. The suben-
docardial T1 time in patients with cardiac amyloid
is shorter than normal individuals and the decrease
is inversely correlated with markers of cardiac
amyloid load such as LV mass, wall thickness,
atrial septal thickness and diastolic function [11].
The outlook for such patients is unclear in the ab-
sence of specific therapy.
Less frequently, mycocardial thickening may
be due to Anderson Fabry disease with cardiac in-
volvement, and this can mimic HCM phenotypical-
ly. However, these patients (50%) typically show
basal inferolateral LV segment hyper-enhancement
with sparing of the subendocardial portion [12].
This case illustrates the value of using CMR
to provide a more integrated investigation in the
central diagnosis and the management of cases of
non-specific cardiomyopathy and apparent wall
thickening and/or infiltration. It also highlights the
critical importance of recognizing the variations and
departure from the norm (as illustrated by the un-
usual pattern of T1 relaxation in this patient). It is
incorrect to simply categorize such individuals as
hypertensive heart disease where several different
pathophysiological processes with variable out-
comes and management structures exist. This dif-
ferentiation may not be possible with standard
screening echocardiography alone.
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